Concepedia

Vishala T. Neppalli

VT

Statistics

Publications

12

Citations

986

H-Index

12

Active since

2006

Affiliations

University of Iowa(Current)

Roswell Park Comprehensive Cancer Center

National Institutes of Health

Memorial Sloan Kettering Cancer Center

Fred Hutch Cancer Center

Vishala T. Neppalli is an author at University of Iowa specializing in medicine, pathology, and hematology.

Top concepts

Publications per year

2006–2021

12

Publications

12

<i>BCL2</i> Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

Javeed Iqbal, Vishala T. Neppalli, George W. Wright et al. · Journal of Clinical Oncology · 2006 · 303 citations · Full text

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018

Shaji Kumar, Natalie S. Callander, Melissa Alsina et al. · Journal of the National Comprehensive Cancer Network · 2018 · 203 citations · Full text

, , +10

Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies

Edmund C. Lee, Michael Fitzgerald, Bret Bannerman et al. · Clinical Cancer Research · 2011 · 106 citations

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

William G. Wierda, John C. Byrd, Jeremy S. Abramson et al. · Journal of the National Comprehensive Cancer Network · 2019 · 94 citations

, , +14

Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: A series of 10 adult and pediatric patients and review of the literature

Christian L. Baum, Brian K. Link, Vishala T. Neppalli et al. · Journal of the American Academy of Dermatology · 2011 · 74 citations

, , +8

1–5 of 12